Alexion Pharmaceuticals Overview

Alexion Pharmaceuticals Operating Income

Operating Income for ALXN.

Quarterly Operating Income

$825.90M

↑ 11.82% YoY

As of Mar 31, 2021

Annual Operating Income (TTM)

$2.95B

↑ 23.76% YoY

Trailing 12 months ending Mar 31, 2021

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin